tiprankstipranks
Telix Pharmaceuticals Ltd. (TLPPF)
OTHER OTC:TLPPF
US Market
TLPPF
Telix Pharmaceuticals
RESEARCH TOOLSreports
Want to see TLPPF full AI Analyst Report?

Telix Pharmaceuticals (TLPPF) Income Statement

180 Followers

Telix Pharmaceuticals Income Statement

Last quarter (Q4 2025), Telix Pharmaceuticals's total revenue was AU$630.94M, an increase of 123.97% from the same quarter last year. In Q4, Telix Pharmaceuticals's net income was AU$-7.38M. See Telix Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
AU$ 1.25BAU$ 783.21MAU$ 502.55MAU$ 160.10MAU$ 7.60M
Gross Profit
AU$ 662.07MAU$ 509.68MAU$ 314.39MAU$ 29.34MAU$ -29.77M
Operating Expenses
AU$ 634.52MAU$ 427.55MAU$ 263.27MAU$ 102.52MAU$ 51.48M
Depreciation and Amortization
AU$ 33.78MAU$ 5.69MAU$ 6.74MAU$ 5.38MAU$ 5.17M
EBITDA
AU$ 61.33MAU$ 92.55MAU$ 22.97MAU$ -92.84MAU$ -70.07M
Operating Income
AU$ 27.55MAU$ 82.13MAU$ 51.89MAU$ -73.18MAU$ -81.25M
Other Income/Expenses
AU$ -35.72MAU$ -26.07MAU$ 0.00AU$ -25.44MAU$ -17.79M
Pretax Income
AU$ -8.17MAU$ 56.06MAU$ 3.09MAU$ -98.62MAU$ -99.04M
Net Income
AU$ -11.05MAU$ 49.92MAU$ 5.21MAU$ -104.08MAU$ -80.51M
Per Share Metrics
Basic EPS
AU$ -0.03AU$ 0.15AU$ 0.02AU$ -0.33AU$ -0.29
Diluted EPS
AU$ -0.03AU$ 0.14AU$ 0.02AU$ -0.33AU$ -0.29
Weighted Average Shares Outstanding
 337.88M 331.23M 319.18M 310.64M 282.21M
Weighted Average Shares Outstanding (Diluted)
 337.88M 345.19M 323.71M 310.64M 282.21M
Currency in AUD

Telix Pharmaceuticals Earnings and Revenue History